The Scientist

» pharmaceuticals and microbiology

Most Recent

image: Adapting to Elevated CO<sub>2</sub>

Adapting to Elevated CO2

By | September 1, 2015

High carbon dioxide levels can irreversibly rev up a cyanobacterium’s ability to fix nitrogen over the long term, a study finds.

2 Comments

image: The Great Big Clean-Up

The Great Big Clean-Up

By | September 1, 2015

From tossing out cross-contaminated cell lines to flagging genomic misnomers, a push is on to tidy up biomedical research.

5 Comments

image: Microorganisms Make a House a Home?

Microorganisms Make a House a Home?

By | August 26, 2015

The fungal and bacterial communities in household dust can reveal some details about a building’s inhabitants.

0 Comments

image: TS Live: Pharma Feast

TS Live: Pharma Feast

By | August 26, 2015

A sampling of the biggest acquisitions reshaping the life sciences industry in 2015

0 Comments

image: Novartis Buys Rights to GSK MS Drug for $1 Billion

Novartis Buys Rights to GSK MS Drug for $1 Billion

By | August 24, 2015

The multiple sclerosis treatment has yet to be tested in Phase 3 clinical trials.

0 Comments

image: Valeant Scoops Sprout for $1 Billion

Valeant Scoops Sprout for $1 Billion

By | August 24, 2015

The Canadian pharmaceutical firm is buying the American drugmaker behind the newly approved “female Viagra.”

0 Comments

image: Bacteria to Blame?

Bacteria to Blame?

By | August 18, 2015

T cells activated in the microbe-dense gut can spark an autoimmune eye disease, a study shows. 

2 Comments

image: The Search for Persisters

The Search for Persisters

By | August 11, 2015

Lyme disease–causing bacteria can outmaneuver antibiotics in vitro and manipulate the mouse immune system.

0 Comments

image: Doctor Who Blocked Thalidomide Dies

Doctor Who Blocked Thalidomide Dies

By | August 11, 2015

Frances Oldham Kelsey, a physician who halted use of a drug that caused birth defects in babies, has passed away at age 101.

0 Comments

image: FDA Approves 3-D–Printed Drug

FDA Approves 3-D–Printed Drug

By | August 4, 2015

The US Food and Drug Administration green lights the first medicine produced by a 3-D printer for use in the human body.

1 Comment

Popular Now

  1. Stroke Alters Gut Microbiome, Impacting Recovery
  2. Next Generation: Nanotube Scaffolds Reconnect Spinal Neurons
  3. Your Office Has a Distinct Microbiome
  4. Will Organs-in-a-Dish Ever Replace Animal Models?
RayBiotech